title: A multicenter survey of childhood asthma in Turkey. II: Utilization of asthma drugs, control levels and their determinants.
abstract: Many surveys worldwide have consistently demonstrated a low level of asthma control and under-utilization of preventive asthma drugs. However, these studies have been frequently criticized for using population-based samples, which include many patients with no or irregular follow-ups. Our aim, in this study, was to define the extent of asthma drug utilization, control levels, and their determinants among children with asthma attending to pediatric asthma centers in Turkey. Asthmatic children (age range: 6-18 yr) with at least 1-yr follow-up seen at 12 asthma outpatient clinics during a 1-month period with scheduled or unscheduled visits were included and were surveyed with a questionnaire-guided interview. Files from the previous year were evaluated retrospectively to document control levels and their determinants. From 618 children allocated, most were mild asthmatics (85.6%). Almost 30% and 15% of children reported current use of emergency service and hospitalization, respectively; and 51.4% and 53.1% of children with persistent and intermittent disease, respectively, were on daily preventive therapy, including inhaled corticosteroids. Disease severity [odds ratio: 12.6 (95% confidence intervals: 5.3-29.8)], hospitalization within the last year [3.4 (1.4-8.2)], no use of inhaled steroids [2.9 (1.1- 7.3)], and female gender [2.3 (1.1-5.4)] were major predictors of poor asthma control as defined by their physicians. In this national pediatric asthma study, we found a low level of disease control and discrepancies between preventive drug usage and disease severity, which shows that the expectations of guidelines have not been met even in facilitated centers, thus indicating the need to revise the severity-based approach of asthma guidelines. Efforts to implement the control-based approach of new guidelines (Global Initiative for Asthma 2006) would be worthwhile.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
authors.forename: O U
authors.initials: OU
authors.lastname: Soyer
authors.forename: N E
authors.initials: NE
authors.lastname: Beyhun
authors.forename: E
authors.initials: E
authors.lastname: Demir
authors.forename: S
authors.initials: S
authors.lastname: Yildirim
authors.forename: A Bingöl
authors.initials: AB
authors.lastname: Boz
authors.forename: N
authors.initials: N
authors.lastname: Altinel
authors.forename: O
authors.initials: O
authors.lastname: Cevit
authors.forename: T
authors.initials: T
authors.lastname: Karakaş
authors.forename: Y
authors.initials: Y
authors.lastname: Anlar
authors.forename: A
authors.initials: A
authors.lastname: Söğüt
authors.forename: D
authors.initials: D
authors.lastname: Altintaş
authors.forename: Y
authors.initials: Y
authors.lastname: Canitez
authors.forename: Z
authors.initials: Z
authors.lastname: Büyükdereli
authors.forename: B E
authors.initials: BE
authors.lastname: Sekerel
mesh_terms: D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000453:epidemiology* / Q000503:physiopathology; D002648:Child; D018450:Disease Progression; D004363:Drug Utilization; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008297:Male; D015337:Multicenter Studies as Topic; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012307:Risk Factors; D012737:Sex Factors; D014421:Turkey
chemical_list: D000305:Adrenal Cortex Hormones